The Global Haematology Special Interest Group (SIG) workplan was created following a stakeholder workshop held in 2016, with representatives from the BSH and haematologists from lower-and-middle income countries (LMIC). One stream of our work was a two year pilot scheme where selected BSH speakers visited LMIC haematology meetings and established links with haematology societies. In 2017 two of our UK representatives spoke at conferences in Ghana and Kenya.
BSH is funding plenary speakers for haematology and transfusion conferences in low-to-middle income countries (LMIC). The aim is to foster partnerships between the BSH and other haematology societies to share knowledge and expertise. During the pilot scheme in 2017/18, BSH selected speakers for conferences in Ghana, Kenya, Egypt and Thailand, with a number of collaborative projects subsequently arising in education, research, and capacity building. Following these successes, BSH is expanding the scheme for 2019/20.
The SIG is looking for a trainee or consultant haematologist to join the two existing Task Force members to help with selecting applicant LMIC societies and speakers, to liaise between them, and to contribute to providing feedback on the scheme to the BSH.
The time commitment is small; a few hours per month. The Task Force collaborates predominantly through email and phone calls, and the wider SIG meets quarterly.
Please send an email briefly detailing your interest in joining the Task Force and any relevant experience, along with CV, to email@example.com
Deadline: 31 August 2019
About the Scheme
The initial phases of this project involved mapping out and making contacts with active haematology and transfusion societies in LMICs worldwide.
A search was undertaken for active haematology societies in LMICs in Africa, Europe, the Middle East and Asia.
Attendees from LMICs at the 2016 BSH international congress were contacted, and respondents asked about active haematology societies in their region. Internet searches were performed and haematologists and transfusion specialists in large teaching hospitals in LMICs were contacted.
LMIC haematology societies were shortlisted for our 2017 pilot scheme based on pre-defined criteria, and the Ghanaian Society of Haematology (GHASH) and the Haematology and Oncology Society of Africa (HOSA) were invited to take part
The 2017 HOSA meeting was titled ‘Haematology in Africa: Beyond Benign; More than Malignant’. They requested a specialist in lymphoma to speak on both diagnosis and management.
The theme of the 2017 GHASH meeting was ‘Anaemia in the Young and Old: Differentials and Challenges’. They requested a speaker who could talk about unusual causes of anaemia and also give advice on developing their laboratory facilities and enrolling in external Quality Assurance schemes.
The committee then advertised for UK consultants with the relevant sub-speciality experience and an interest in ongoing collaboration with our haematology colleagues in LMICs. They were short-listed and interviews were held in June 2017.
Dr Maadh Aldouri was selected to represent the BSH at the HOSA conference in Nairobi, Kenya in August 2017. His plenary lecture on lymphoma in a low resource setting was well received.
At the conference he also had the opportunity to take part in a sickle cell neonatal screening workshop, and following the conference he visited Agha Khan University and Nairobi University Hospitals to meet with their haematologists and trainees.
Dr Humayun Ahmad represented the BSH at the GHASH conference in Accra, Ghana in November 2017. In addition to giving the plenary talk on the differential causes of anaemia, he also provided tutorials for trainees and staff.
As part of an ongoing collaboration, arrangements are being made for clinical attachments in the UK for Ghanaian haematology trainees.
A further round of Plenary Speakers is planned for 2018. The scheme is undergoing in depth qualitative feedback and evaluation to assess short-term and longer-term potential impact in fostering BSH-LMIC collaborations particularly in teaching, research and clinical practice and guidelines.